Private equity firms are becoming increasingly influential in American healthcare, acquiring hospitals, physician practices, nursing homes and hospice providers. These investments can bring capital, technology and operational expertise. However, growing evidence is raising questions about whether financial restructuring can sometimes undermine patient care.
The debate gained fresh attention in November 2026 after a new Health Affairs study examined private equity acquisitions of hospice providers. Researchers compared 191 acquired hospices with 1,305 similar providers. They found that average patient stays increased by 6.3 days and Medicare spending rose by $993 per encounter relative to the comparison group. Researchers also identified changes in patient selection, highlighting how payment incentives can influence care delivery.
When Financial Restructuring Meets Patient Care
Private equity investments often involve borrowing, restructuring operations and eventually selling businesses for a return. In healthcare, these strategies can affect staffing, service availability, facility finances and clinical decision-making.
A 2025 study published in the Annals of Internal Medicine examined staffing and outcomes at hospitals acquired by private equity firms. Researchers found relative reductions in emergency department and intensive care unit salary expenditures. They also observed increased emergency department mortality and transfers to other hospitals. The study examined specific hospitals and Medicare populations, so its findings should not be generalized to every acquisition.
Another Health Affairs study published in 2025 found a 2.7-percentage-point increase in 30-day postoperative mortality after private equity acquisition among patients undergoing selected common surgeries. The increase was primarily associated with failures to rescue patients after complications.

Nursing Homes and Hospital Ownership Under Scrutiny
The concerns extend beyond acute-care hospitals. A 2025 systematic review of U.S. nursing home research linked private equity ownership with more care deficiencies, hospitalizations and higher mortality in several studies. Researchers also identified staffing reductions and financial pressures associated with debt.
However, the evidence is not uniformly negative. A 2026 JAMA Health Forum study found no meaningful short-term increase in hospitalizations among traditional Medicare beneficiaries after primary care acquisitions. Results varied by healthcare setting, reinforcing the importance of evaluating individual transactions and outcomes.
Regulators Face Pressure for Greater Transparency
The federal government has already increased scrutiny. The FTC, Justice Department and HHS launched a joint inquiry into corporate ownership and healthcare transactions in 2024.
In 2026, the American College of Physicians called for stronger oversight, ownership transparency and safeguards protecting physician independence.
Ultimately, private investment is not automatically harmful, nor does every acquisition produce better care. The challenge is ensuring that financial returns do not take priority over safe staffing, affordable treatment and clinical judgment. For patients, the real measure of healthcare investment should be the quality and accessibility of care.
#Healthcare #PrivateEquity #PatientCare #HospitalOwnership #WallStreet #HealthcareIndustry #NursingHomes #Medicare #HealthcarePolicy